Home
About
Committees
RSVP
Sponsor
News
Inductees
Nominate
Melanoma
Steven A. Rosenberg, MD, PhD
National Cancer Institute
Father of Immunotherapy
Pioneered the use of adoptive immunotherapy.
Chief of Surgery at the National Cancer Institute.
Credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer.
Has shown that expanding immune cells (known as tumor infiltrating lymphocytes) in the lab can be used to treat patients with melanoma.